Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort.
Kwak N, Henkle E, Hwang H, Jeon D, Jhun BW, Jo KW, Kang YA, Kim HJ, Kim JY, Kim YR, Kwon YS, Lee JH, Mok J, Park Y, Shim TS, Sohn H, Whang J, Yim JJ. Kwak N, et al. Among authors: kwon ys. Clin Infect Dis. 2024 Apr 2:ciae131. doi: 10.1093/cid/ciae131. Online ahead of print. Clin Infect Dis. 2024. PMID: 38563246
Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial.
Kwak N, Jeon D, Park Y, Kang YA, Kim KJ, Kim YR, Kwon BS, Kwon YS, Kim HJ, Lee JH, Lee JY, Lee JK, Mok J, Cheon M, Park J, Hahn S, Yim JJ. Kwak N, et al. Among authors: kwon ys, kwon bs. Trials. 2022 Aug 17;23(1):666. doi: 10.1186/s13063-022-06631-z. Trials. 2022. PMID: 35978342 Free PMC article.
A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea.
Shim TS, Pai H, Mok J, Lee SH, Kwon YS, Choi JC, Park J, Birmingham E, Mao G, Alquier L, Davis K, Thoret-Bauchet F, Kim JH, Kim H, Bakare N. Shim TS, et al. Among authors: kwon ys. BMC Infect Dis. 2023 Jan 9;23(1):15. doi: 10.1186/s12879-022-07955-6. BMC Infect Dis. 2023. PMID: 36624432 Free PMC article.
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
Koh WJ, Lee SH, Kang YA, Lee CH, Choi JC, Lee JH, Jang SH, Yoo KH, Jung KH, Kim KU, Choi SB, Ryu YJ, Chan Kim K, Um S, Kwon YS, Kim YH, Choi WI, Jeon K, Hwang YI, Kim SJ, Lee YS, Heo EY, Lee J, Ki YW, Shim TS, Yim JJ. Koh WJ, et al. Among authors: kwon ys. Am J Respir Crit Care Med. 2013 Oct 1;188(7):858-64. doi: 10.1164/rccm.201303-0604OC. Am J Respir Crit Care Med. 2013. PMID: 23927582 Clinical Trial.
Choice between Levofloxacin and Moxifloxacin and Multidrug-Resistant Tuberculosis Treatment Outcomes.
Kang YA, Shim TS, Koh WJ, Lee SH, Lee CH, Choi JC, Lee JH, Jang SH, Yoo KH, Jung KH, Kim KU, Choi SB, Ryu YJ, Kim KC, Um S, Kwon YS, Kim YH, Choi WI, Jeon K, Hwang YI, Kim SJ, Lee HK, Heo E, Yim JJ. Kang YA, et al. Among authors: kwon ys. Ann Am Thorac Soc. 2016 Mar;13(3):364-70. doi: 10.1513/AnnalsATS.201510-690BC. Ann Am Thorac Soc. 2016. PMID: 26871879 Clinical Trial.
Developing a Diagnostic Bundle for Bronchiectasis in South Korea: A Modified Delphi Consensus Study.
Choi H, Lee H, Ra SW, Jang JG, Lee JH, Jhun BW, Park HY, Jung JY, Lee SJ, Jo KW, Rhee CK, Kim C, Lee SW, Min KH, Kwon YS, Kim DK, Lee JH, Park YB, Chung EH, Kim YJ, Yoo KH, Oh YM. Choi H, et al. Among authors: kwon ys. Tuberc Respir Dis (Seoul). 2022 Jan;85(1):56-66. doi: 10.4046/trd.2021.0136. Epub 2021 Nov 15. Tuberc Respir Dis (Seoul). 2022. PMID: 34775738 Free PMC article.
793 results